It’s no secret that the COVID-19 pandemic drove a rapid increase in the adoption of decentralized clinical trials (DCTs) across the life sciences industry. Utilizing digital technologies has demonstrated ample benefits to sponsors, study teams and importantly, patients. These benefits include increasing efficiency across clinical operations and data management, simplifying the sponsor technology ecosystem, reducing patient and site burden, accelerating timelines, providing access to real-time data and insights, improving access to more diverse patient populations and more.
Now that many sponsors are embracing DCT strategies, these organizations will need to focus on scaling their approach in implementing digital capabilities to ensure long-term success and achieving a positive ROI. To achieve scale, digital strategies need to be embedded early into the pipeline of pharma and biotech companies, requiring the creation of standardized processes and an ecosystem of partners who work together to achieve a common goal.
Register for this webinar where a panel of industry experts from Medable, Syneos and Veeva will provide best practices and examples on how to successfully implement and scale patient-first DCTs across an organization to drive transformation of the clinical development process while mitigating potential risks.
Speakers
Call for Papers
Event Schedule
Go to Event WebsiteAdvertisements